Conveyor Therapeutics

Conveyor’s ADCs enhance the efficacy of clinically validated mAbs by delivering immunosuppressive payloads with complementary modes of action.

Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
NewCo
Initial Investment Year
2024
Conveyor Therapeutics logo